These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 9328574)
1. Very low density lipoproteins and interleukin 2 enhance the immunogenicity of 9-O-acetyl-GD3 ganglioside in BALB/c mice. Dumontet C; Rebbaa A; Portoukalian J J Immunol Methods; 1997 Aug; 206(1-2):115-23. PubMed ID: 9328574 [TBL] [Abstract][Full Text] [Related]
2. Analysis of the antibody response to immunization with purified O-acetyl GD3 gangliosides in patients with malignant melanoma. Ritter G; Ritter-Boosfeld E; Adluri R; Calves M; Ren S; Yu RK; Oettgen HF; Old LJ; Livingston PO Int J Cancer; 1995 Sep; 62(6):668-72. PubMed ID: 7558412 [TBL] [Abstract][Full Text] [Related]
3. GD3 vaccines for melanoma: superior immunogenicity of keyhole limpet hemocyanin conjugate vaccines. Helling F; Shang A; Calves M; Zhang S; Ren S; Yu RK; Oettgen HF; Livingston PO Cancer Res; 1994 Jan; 54(1):197-203. PubMed ID: 8261439 [TBL] [Abstract][Full Text] [Related]
4. Immunogenicity of melanoma-associated gangliosides in cancer patients. Tai T; Cahan LD; Tsuchida T; Saxton RE; Irie RF; Morton DL Int J Cancer; 1985 May; 35(5):607-12. PubMed ID: 3997282 [TBL] [Abstract][Full Text] [Related]
5. Antibody response to immunization with purified GD3 ganglioside and GD3 derivatives (lactones, amide and gangliosidol) in the mouse. Ritter G; Boosfeld E; Calves MJ; Oettgen HF; Old LJ; Livingston PO Immunobiology; 1990 Dec; 182(1):32-43. PubMed ID: 2098322 [TBL] [Abstract][Full Text] [Related]
6. An epitope common to gangliosides O-acetyl-GD3 and GD3 recognized by antibodies in melanoma patients after active specific immunotherapy. Ravindranath MH; Morton DL; Irie RF Cancer Res; 1989 Jul; 49(14):3891-7. PubMed ID: 2472199 [TBL] [Abstract][Full Text] [Related]
8. Specific serological response by active immunization with GD3-bearing liposomes. Massó O; Aliño SF; Lejarreta M; Blasco F; Piulats J J Pharmacol Exp Ther; 1996 Sep; 278(3):1114-20. PubMed ID: 8819493 [TBL] [Abstract][Full Text] [Related]
9. Attachment of monophosphoryl lipid A (MPL) to cells and liposomes augments antibody response to membrane-bound gangliosides. Ravindranath MH; Morton DL; Irie RF J Autoimmun; 1994 Dec; 7(6):803-16. PubMed ID: 7888037 [TBL] [Abstract][Full Text] [Related]
10. Enhancement of the immune response to poorly immunogenic gangliosides after incorporation into very small size proteoliposomes (VSSP). Estevez F; Carr A; Solorzano L; Valiente O; Mesa C; Barroso O; Sierra GV; Fernandez LE Vaccine; 1999 Aug; 18(1-2):190-7. PubMed ID: 10501249 [TBL] [Abstract][Full Text] [Related]
11. Serological response of non-human primates to human melanoma disialoganglioside GD3. Stuhlmiller GM; Roberson KM; Seigler HF Cancer Immunol Immunother; 1989; 29(3):205-10. PubMed ID: 2731185 [TBL] [Abstract][Full Text] [Related]
12. Biosynthesis and turnover of O-acetyl and N-acetyl groups in the gangliosides of human melanoma cells. Manzi AE; Sjoberg ER; Diaz S; Varki A J Biol Chem; 1990 Aug; 265(22):13091-103. PubMed ID: 2198284 [TBL] [Abstract][Full Text] [Related]
13. Human melanoma antigen O-acetylated ganglioside GD3 is recognized by Cancer antennarius lectin. Ravindranaths MH; Paulson JC; Irie RF J Biol Chem; 1988 Feb; 263(4):2079-86. PubMed ID: 3339003 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of immune cell proliferation and cytokine production by lipoprotein-bound gangliosides. Dumontet C; Rebbaa A; Bienvenu J; Portoukalian J Cancer Immunol Immunother; 1994 May; 38(5):311-6. PubMed ID: 8162613 [TBL] [Abstract][Full Text] [Related]
15. GD3, a prominent ganglioside of human melanoma. Detection and characterisation by mouse monoclonal antibody. Pukel CS; Lloyd KO; Travassos LR; Dippold WG; Oettgen HF; Old LJ J Exp Med; 1982 Apr; 155(4):1133-47. PubMed ID: 7061953 [TBL] [Abstract][Full Text] [Related]
16. Antibody responses to ganglio-series gangliosides in different strains of inbred mice. Kawashima I; Nakamura O; Tai T Mol Immunol; 1992 May; 29(5):625-32. PubMed ID: 1584231 [TBL] [Abstract][Full Text] [Related]
17. Structural and immunological characterization of O-acetylated GD2. Evidence that GD2 is an acceptor for ganglioside O-acetyltransferase in human melanoma cells. Sjoberg ER; Manzi AE; Khoo KH; Dell A; Varki A J Biol Chem; 1992 Aug; 267(23):16200-11. PubMed ID: 1644805 [TBL] [Abstract][Full Text] [Related]
18. Approaches to augmenting the immunogenicity of melanoma gangliosides: from whole melanoma cells to ganglioside-KLH conjugate vaccines. Livingston PO Immunol Rev; 1995 Jun; 145():147-66. PubMed ID: 7590824 [TBL] [Abstract][Full Text] [Related]
19. Recombinant antibodies against ganglioside expressed on tumor cells. Hanai N; Nakamura K; Shitara K Cancer Chemother Pharmacol; 2000; 46 Suppl():S13-7. PubMed ID: 10950141 [TBL] [Abstract][Full Text] [Related]
20. Biochemical and serological characteristics of natural 9-O-acetyl GD3 from human melanoma and bovine buttermilk and chemically O-acetylated GD3. Ritter G; Boosfeld E; Markstein E; Yu RK; Ren SL; Stallcup WB; Oettgen HF; Old LJ; Livingston PO Cancer Res; 1990 Mar; 50(5):1403-10. PubMed ID: 2302705 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]